http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015005390-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_051f9620a6e82f6e316aef1e4b9a5711 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-085 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-085 |
| filingDate | 2013-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5333c20899179946d71920e9bc10e4c7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ebf0280301348a8c29861318d7d084c7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_903aca8d03c6208c103c521211ad8b69 |
| publicationDate | 2015-01-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2015005390-A1 |
| titleOfInvention | Method for treating inflammatory disorder |
| abstract | The present invention relates to a method for treating inflammatory disorder, comprising administering to a subject in need thereof a therapeutically effective amount of a compound of 2-methoxy-4-methylphenol or a pharmaceutically acceptable salt or a physiologically functional derivative thereof, wherein the compound is in a therapeutically effective amount to inhibit NO or IL-6 expression, caspase-1 activation or IL-1β secretion, and NLRP3 and IL-1β precursor expression in inflammatory cells of the subject. |
| priorityDate | 2013-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 237.